A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
Joint Clinical Research Centre, Mbale, Mbale, Uganda
Moi University Clinical Research Centre, Eldoret, Kenya
KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
Central Hospital of China Aerospace Corporation, Beijing, Beijing, China
Tongji Hospital, Medical College Huazhong, Wuhan, Hubei, China
Asociación Civil Selva Amazónica, Iquitos, Peru
Mokali health area of Biyela health zone, in Kinshasa province., Kinshasa, Kinshasa province, Congo
KEMRI-Wellcome Trust Programme, Nairobi, Kenya
Saint Louis Nutrition Project, Blantyre, Malawi
St. Louis Nutrition Project, Blantyre, Malawi
Medical research Unit of Lambaréné, Lambarene, Moyen ogooue, Gabon
Institut Pasteur in Cambodia, Clinical Pathology Unit, Phnom Penh, Cambodia
Instituto René Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil
Department of Medical Laboratory Sciences and Pathology , College of Public Health and Medical Sciences, Jimma University, Jimma,, Ethiopia
Vector Control Division, Kampala, Uganda
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.